Expression of COX‐2, mPGE‐synthase 1 , MDR‐1 (P‐gp), and Bcl‐x L : a molecular pathway of H pylori ‐related gastric carcinogenesis

Abstract Helicobacter pylori up‐regulates cyclo‐oxygenase‐2 (COX‐2) expression, which in turn is involved in tumourigenesis. Recently, a causal link between COX‐2 and multidrug resistance 1 ( MDR‐1 ) gene expression, implicated in cancer chemoresistance, has been demonstrated. Thus, the expression o...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pathology Vol. 202; no. 3; pp. 305 - 312
Main Authors Nardone, Gerardo, Rocco, Alba, Vaira, Dino, Staibano, Stefania, Budillon, Alfredo, Tatangelo, Fabiana, Sciulli, Maria G., Perna, Federico, Salvatore, Gaetano, Di Benedetto, Maria, De Rosa, Gaetano, Patrignani, Paola
Format Journal Article
LanguageEnglish
Published 01.03.2004
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Helicobacter pylori up‐regulates cyclo‐oxygenase‐2 (COX‐2) expression, which in turn is involved in tumourigenesis. Recently, a causal link between COX‐2 and multidrug resistance 1 ( MDR‐1 ) gene expression, implicated in cancer chemoresistance, has been demonstrated. Thus, the expression of COX‐2 and the downstream enzyme involved in PGE 2 biosynthesis, microsomal PGE‐synthase 1 (mPGES 1 ), was correlated with P‐gp, the product of MDR‐1 , and the anti‐apoptotic protein, Bcl‐x L , in gastric biopsies from patients with H pylori infection and in patients with gastric cancer. In a retrospective analysis of endoscopic and pathology files, 40 H pylori ‐negative patients ( Hp −), 50 H pylori ‐positive patients who responded to eradication therapy ( Hp +R), 84 H pylori ‐positive patients who did not respond to eradication therapy ( Hp +NR), and 30 patients with gastric cancer (18 intestinal and 12 diffuse types) were selected. COX‐2, mPGES 1 , P‐gp, and Bcl‐x L were detected by immunohistochemistry. COX‐2, mPGES 1 , P‐gp, and Bcl‐x L expression was undetectable in gastric mucosa from Hp − patients. By contrast, COX‐2 and mPGES 1 expression was detected in 42% and 44% of Hp +R patients, respectively, and in up to 66% (range 63–66%) of Hp +NR patients ( p < 0.05). The expression of COX‐2 and mPGES 1 correlated significantly ( p < 0.0001) with that of P‐gp and Bcl‐x L . High levels of COX‐2, mPGES 1 , P‐gp, and Bcl‐x L expression were found in intestinal‐type gastric cancer samples. In conclusion, H pylori ‐dependent induction of COX‐2 and mPGES 1 is associated with enhanced production of P‐gp and Bcl‐x L that may contribute to gastric tumourigenesis and resistance to therapy. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
ISSN:0022-3417
1096-9896
DOI:10.1002/path.1512